Does RISANKIZUMAB-RZAA Cause Obstruction? 190 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 190 reports of Obstruction have been filed in association with RISANKIZUMAB-RZAA. This represents 0.3% of all adverse event reports for RISANKIZUMAB-RZAA.
190
Reports of Obstruction with RISANKIZUMAB-RZAA
0.3%
of all RISANKIZUMAB-RZAA reports
1
Deaths
108
Hospitalizations
How Dangerous Is Obstruction From RISANKIZUMAB-RZAA?
Of the 190 reports, 1 (0.5%) resulted in death, 108 (56.8%) required hospitalization.
Is Obstruction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 190 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Obstruction?
ADALIMUMAB (850)
PREDNISONE (289)
ALBUTEROL (251)
INFLIXIMAB (167)
PANTOPRAZOLE (152)
MONTELUKAST (146)
TIOTROPIUM (132)
TEDUGLUTIDE (128)
HUMAN IMMUNOGLOBULIN G (119)
GABAPENTIN (106)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Obstruction Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA